Advertisement

Evasion Strategies of Microorganisms

  • M. M. Frank
Conference paper

Abstract

There are three principal mechanisms by which complement controls invasion by microorganisms(Frank 1988). Binding of complement to the surface of an organism leads to the sequential activation of components C5 to C9 with formation of a complex of these proteins (the membrane attack complex). The complex has a hydrophobic surface and inserts into cell membrane lipid of the microorganism. This cylinder like structure has a hydrophilic central axis and destabilizes the osmotic regulation of the organism causing cell death. In the case of gram negative organisms, insertion of the C5b-9 complex appears to occur principally in the outer membrane. The precise mechanisms for dissolution of the inner or cytoplasmic membrane is unknown and the ultimate cause of death of these organisms is unknown(Taylor 1988). Enveloped viruses may have typical complement lesions formed in their membranes upon attack leading to loss of viral integrity(Cooper 1986). Parasites such as, promastigotes of Leishmania and Schistosoma mansoni cercaria undergo direct membrane attack and dissolution(Joiner 1988).

Keywords

Sialic Acid Classical Pathway Complement Protein Schistosoma Mansoni Membrane Attack Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baker CJ, Edwards MS, Webb BJ, Kasper DL (1982) J Clin Invest 69:394–404PubMedCentralPubMedCrossRefGoogle Scholar
  2. Blaser MJ, Smith PF, Repine JE, Joiner KA (1988) J Clin Invest 81:1434–1344PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bobak DA, Washburn RG, Frank MM (1988) J Immunol 141:592–597PubMedGoogle Scholar
  4. Brown EJ, Joiner KA (1988) Mechanism of host resistance to infection in immunological diseases. In: Samter M (ed) Immunological Diseases. Little Brown, Boston, p 715Google Scholar
  5. Bullock WE, Wright SD (1987) J Exp Med 165:195–210PubMedCrossRefGoogle Scholar
  6. Chen CC, Cleary PP (1989) Infect Immun 57:1740PubMedCentralPubMedGoogle Scholar
  7. Cooper NR, Nemerow GR (1986) Complement-dependent mechanisms of viral neutralization. In: Ross G (ed) Immunobiology of the complement system. Academic Press, New York, p 139CrossRefGoogle Scholar
  8. Edwards JE Jr, Gaither TA, O’Shea JJ, Rotrosen D, Lawley TJ, Wright SA, Frank MM, Green I (1986) J Immunol 137:3577–3583PubMedGoogle Scholar
  9. Fitzgerald TJ (1987) Infect Immun 55:2066–2073PubMedCentralPubMedGoogle Scholar
  10. Frank MM, Fries LF (1988) The role of complement in defense against bacterial disease. In: Bailliere’s Clinical Immunology and Allergy, vol 2, p 325Google Scholar
  11. Fries LF III, Frank MM (1987) Molecular mechanisms of complement action. In: Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus PW (eds) The molecular basis of blood diseases. WB Saunders, Philadelphia, p 450Google Scholar
  12. Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM (1986) J Immunol 137:1636PubMedGoogle Scholar
  13. Heidenreich F, Dierich MP (1985) Infect Immun 50:598PubMedCentralPubMedGoogle Scholar
  14. Horstmann RD, Sievertsen HJ, Knoblock J, Fischetti VA (1988) Proc Natl Acad Sci USA 85:1657PubMedCentralPubMedCrossRefGoogle Scholar
  15. Horwitz M (1988) Phagocytosis and intracellular biology of Legionella pneumophila. In: Cabello FC, Pruzzo C (eds) Bacteria, complement and the phagocytic cell, Springer-Verlag, Berlin, p 231CrossRefGoogle Scholar
  16. Jarvis GA, Vedros NA (1987) Infect Immun 55:174–80PubMedCentralPubMedGoogle Scholar
  17. Jimenez-Lucho VF, Joiner KA, Foulds J, Frank MM, Leive L (1987) J Immunol 139:1253–1259PubMedGoogle Scholar
  18. Joiner KA (1988) Complement evasion by bacteria and parasites. Ann Rev Microbiol 42:201–230CrossRefGoogle Scholar
  19. Joiner KA, Brown EJ, Frank MM (1984) Complement and bacteria: chemistry and biology in host defense. Ann Rev Immunol 2:461–91CrossRefGoogle Scholar
  20. Joiner KA, Grossman N, Schmetz M, Leive L (1986) J Immunol 136:710PubMedGoogle Scholar
  21. Joiner KA, da Silva WD, Rimoldi MT, Hammer CH, Sher A, Kipnis TL (1988) J Biol Chem 263:11327–35PubMedGoogle Scholar
  22. Kochi SK, Johnson RC (1988) Infect Immun 56:314–321PubMedCentralPubMedGoogle Scholar
  23. Kotwal GJ, Moss B (1988) Nature 335:176PubMedCrossRefGoogle Scholar
  24. Levy NJ, Kasper DL (1986) J Immunol 136:4157–4162PubMedGoogle Scholar
  25. Loos M, Clas F (1987) Immunol Lett 14:203–208PubMedCrossRefGoogle Scholar
  26. Makela PH, Houi M, Saxen H, Valtonen M, Valtonen V (1988) Ability to activate the alternative complement pathway as a virulence determinant in Salmonella. In: Cabello, Pruzzo C (eds) Bacteria, complement and the phagocytic cell. Springer Verlag, Berlin, p 157CrossRefGoogle Scholar
  27. Malbran A, Frank MM, Fries LF (1987) Immunol 61:15–20Google Scholar
  28. McNearney TA, Odell C, Holers VM, Spear PG, Atkinson JP (1987) J Exp Med 166:1525–1535PubMedCrossRefGoogle Scholar
  29. Mold C, Bradt BM, Nemerow GR, Cooper NR (1988) J Exp Med 168:949PubMedCrossRefGoogle Scholar
  30. Molla A, Araike T, Maeda M (1989) Infect Immun 57:1868PubMedCentralPubMedGoogle Scholar
  31. Nemerow GR, Mold C, Keivens-Schwend V, Tollefson V, Cooper NR (1987) J Virol 61:1416PubMedCentralPubMedGoogle Scholar
  32. Perrin LH, Joseph BS, Cooper NR, Oldstone MBA (1982), J Exp Med 143:1027–1041Google Scholar
  33. Porterfield JS (1986) Antibody-dependent enhancement of viral infectivity. In: Advances in Virus Research, vol 31. Academic Press, Inc., NY, p 335Google Scholar
  34. Robinson WE Jr, Montefiori DC, Mitchell WM (1988) Lancet 6: 790–794CrossRefGoogle Scholar
  35. Ryan US, Schultz DR, Goodwin JD, Vann JM, Seivaraj MP, Hart MA (1989) Infect Immun 57:1356–1362PubMedCentralPubMedGoogle Scholar
  36. Schiller NL, Hatch RA, Joiner KA (1989) Infect Immun 57:1707–1713PubMedCentralPubMedGoogle Scholar
  37. Taylor PW (1988) The mode of C5b-9 attack on susceptible gram negative bacteria. In: Cabello FC, Pruzzo C (eds) Bacteria, complement and the phagocytic cell. Springer-Verlag, Berlin, p 12 9Google Scholar
  38. Tenner AJ, Ziccardi RJ, Cooper NR (1984) J Immunol 133:886–891PubMedGoogle Scholar
  39. Tenner AJ, Frank MM (1986) J Immunol 137:625–630PubMedGoogle Scholar
  40. Valentin-Weigand P, Grulich-Henn J, Chhatwal GS, Muller-Berghaus, Blobel H, Preissner KT (1988) Infect Immun 56:2851–55PubMedCentralPubMedGoogle Scholar
  41. Vasantha S, Coelingh KL, Murphy BR, Dourmashkin RR, Hammer CH, Frank MM, Fries LF (1988) Virology 167:433–41PubMedGoogle Scholar
  42. Vermeulen C, Cross A, Byren WR, Zollinger W (1988) Infect Immun 56:2723–2730PubMedCentralPubMedGoogle Scholar
  43. Ward PA, Jack RM (1981) Am J Pathol 102:109–113PubMedCentralPubMedGoogle Scholar
  44. Whitnack E, Poirier TP, Beachey EH (1988) Complement-mediated opsonization of group A streptococci inhibited by the binding of fibrinogen to surface M protein fibrillae. In: Cabello CF, Pruzzo C (eds) Bacteria, complement and the phagocytic cell. Springer Verlag, BerlinGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. M. Frank

There are no affiliations available

Personalised recommendations